Obsessive-Compulsive Disorder: Pramipexole Treatment Study

We are investigating whether pramipexole can improve treatment outcomes for individuals with resistant OCD. The study will also assess the safety of this medication and its effects on brain function.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Pramipexol Aurobindo
Pramipexol Aurobindo is a medicine used to treat symptoms of Parkinson’s disease and restless legs syndrome.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Pramipexole
Pramipexole is a substance that helps ease Parkinson's movement symptoms and reduces restless legs by acting like dopamine in the brain.
Pramipexole Dihydrochloride Monohydrate
Pramipexole helps improve movement in Parkinson's disease and eases uncomfortable leg sensations from restless legs syndrome.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Calmolan
Calmolan Retard
Derinik

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
CCAB Centro Clinico Academico Braga Associacao
Psychiatry
Gualtar, Portugal
Sponsor: CCAB Centro Clinico Academico Braga Associacao
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.